Primary Analysis of Phase 2 Results for Cemiplimab, a Human Monoclonal Anti-PD-1, in Patients with Metastatic Cutaneous Squamous Cell Carcinoma. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 2, p. S79, 2018. DOI: 10.25251/skin.2.supp.79. Disponível em: https://skin.dermsquared.com/skin/article/view/475. Acesso em: 8 jun. 2025.